These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20492672)

  • 1. Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).
    Xia YY; Hu DY; Liu FY; Wang XM; Yuan YL; Tu DH; Chen YX; Zhou L; Zhu LZ; Gao WW; Wang HY; Chen da F; Yang L; He PP; Li XT; He YJ; Sun F; Zhan SY
    BMC Public Health; 2010 May; 10():267. PubMed ID: 20492672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study.
    Lv X; Tang S; Xia Y; Wang X; Yuan Y; Hu D; Liu F; Wu S; Zhang Y; Yang Z; Tu D; Chen Y; Deng P; Ma Y; Chen R; Zhan S
    PLoS One; 2013; 8(6):e65037. PubMed ID: 23750225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
    Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
    Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study.
    Yang M; Pan H; Lu L; He X; Chen H; Tao B; Liu W; Yi H; Tang S
    BMJ Open; 2019 Mar; 9(3):e027321. PubMed ID: 30928962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.
    Shang P; Xia Y; Liu F; Wang X; Yuan Y; Hu D; Tu D; Chen Y; Deng P; Cheng S; Zhou L; Ma Y; Zhu L; Gao W; Wang H; Chen D; Yang L; He P; Wu S; Tang S; Lv X; Shu Z; Zhang Y; Yang Z; Chen Y; Li N; Sun F; Li X; He Y; Garner P; Zhan S
    PLoS One; 2011; 6(7):e21836. PubMed ID: 21750735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions in tuberculosis and management.
    Prasad R; Singh A; Gupta N
    Indian J Tuberc; 2019 Oct; 66(4):520-532. PubMed ID: 31813444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients.
    Wu S; Xia Y; Lv X; Tang S; Yang Z; Zhang Y; Wang X; Hu D; Liu F; Yuan Y; Tu D; Sun F; Zhou L; Zhan S
    J Gastroenterol Hepatol; 2015 Mar; 30(3):540-5. PubMed ID: 25160904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study.
    Choi H; Park HA; Hyun IG; Kim JH; Hwang YI; Jang SH; Sim YS; Shin TR; Ko Y; Ban GY; Hong JY; Lee CY; Lee MG; Choi JH
    Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1153-1163. PubMed ID: 35909258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of adverse reactions induced by anti-tuberculosis drugs among hospitalized patients in Wuhan, China: A retrospective study.
    Shi C; Yang B; Yang J; Song W; Chen Y; Zhang S; Zhan H; Xiong Y; Rong P; Luo Y; Yang J
    Medicine (Baltimore); 2024 May; 103(20):e38273. PubMed ID: 38758847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between lncRNA AC079767.4 variants and liver injury from antituberculosis treatment in West China.
    Zhao Z; Peng W; Wu L; Ying B
    J Infect Chemother; 2020 Jan; 26(1):63-68. PubMed ID: 31405785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study.
    Arriaga MB; Torres NMC; Araujo NCN; Caldas SCC; Andrade BB; Netto EM
    PLoS One; 2019; 14(12):e0227101. PubMed ID: 31877199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
    Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
    Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases.
    Jones J; Mudaly V; Voget J; Naledi T; Maartens G; Cohen K
    BMC Infect Dis; 2019 Jun; 19(1):544. PubMed ID: 31221100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study.
    Chen S; Pan H; Chen Y; Lu L; He X; Chen H; Chen R; Zhan S; Tang S
    Sci Rep; 2019 Oct; 9(1):14311. PubMed ID: 31586142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports.
    Njuguna C; Stewart A; Mouton JP; Blockman M; Maartens G; Swart A; Chisholm B; Jones J; Dheda M; Igumbor EU; Cohen K
    Drug Saf; 2016 Feb; 39(2):159-69. PubMed ID: 26547719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systematic review of anti-tuberculosis drug induced adverse reactions in China].
    Xia YY; Zhan SY
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):419-23. PubMed ID: 17673012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.
    P V K; Palaian S; Ojha P; P R S
    Pak J Pharm Sci; 2008 Jan; 21(1):51-6. PubMed ID: 18166520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis.
    Laghari M; Talpur BA; Syed Sulaiman SA; Khan AH; Bhatti Z
    Int J Mycobacteriol; 2020; 9(3):281-288. PubMed ID: 32862161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the prevalence and effect of adverse drug reactions among patients receiving first line anti-tubercular medicines in the Tamale Teaching Hospital, Ghana.
    Amalba A; Bugri AA
    Pan Afr Med J; 2021; 38():191. PubMed ID: 33995797
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.